Policies should be written and enforced for abbreviation usage. (2) In 2004 the Joint Commission created its “do not use” list of abbreviations as part of the requirements for meeting that goal. In 2010, NPSG.02.02.01 was integrated into the Information Management standards as elements of performance 2 and 3 under IM.02.02.01. The policies should also contain the use of comely misused symbols . Physicians’ need to write more legible when using abbreviations as well.
Abbreviations are not always acceptable and not always necessary, and not everyone
should use them. There are a lot of abbreviations out there in the medical field and only
people who are trained in them should be using them. (3) Some abbreviations, symbols
and dose designations are frequently misinterpreted and lead to mistakes that result in
patient harm. The ISMP-FDA campaign seeks to promote safe practices and prevent
serious and even potentially fatal mistakes when communicating medication orders.
The campaign focuses on eliminating the use of error-prone abbreviations by healthcare
professionals and students, medical communications and publishing professionals, the
pharmaceutical industry, and FDA staff. ISMP and the FDA plan to reach those audiences
through targeted educational materials, articles in professional journals, and presentations
at key conferences and meetings....